Medivir to present at the 2019 BIO International Convention

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the 2019 BIO International Convention in Philadelphia, US. The presentation will take place at 11.30am local time on Wednesday, June 5, 2019. Christina Herder, EVP Strategic Business Development, will present the developments in the company’s project portfolio. The presentation will be available via Medivirs website; www.medivir.com. For further information, please contact:Uli Hacksell, CEO, Medivir AB, mobile: +46 (0)73 125 0615. About MedivirMedivir develops innovative drugs